Receptor-interacting protein kinase 3 as a predictive adjuvant chemotherapy marker after lung adenocarcinoma resection

DOI: 10.21037/atm.2018.12.65

Keywords: Receptor-interacting protein kinase 3 (RIPK3), lung adenocarcinoma (LUAD), cisplatin, adjuvant chemotherapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text